Lars B. Abrahmsen, SVP, Chief Scientific Officer at Aprea Therapeutics, Inc. (APRE), sold 25,000 shares at $4.97 ($124K) on 2021-09-20, disclosed to the SEC on 2021-09-22.
Open-market sale of $124k APRE by SVP, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.